Drug Profile
PF 4455242
Alternative Names: PF-04455242Latest Information Update: 29 Sep 2010
Price :
$50
*
At a glance
- Originator Pfizer
- Class Neuropsychotherapeutics
- Mechanism of Action Opioid kappa receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bipolar depression
Most Recent Events
- 27 Sep 2010 Discontinued - Phase-I for Bipolar depression in USA (PO)
- 30 Apr 2009 Phase-I clinical trials in Bipolar depression in USA (PO)